September 09, 2024

Bariatric Surgery Outperformed Meds for Hypertension Control

Meta-analysis reveals bariatric surgery patients 7 times more likely to reduce antihypertensive medications compared to conventional treatment.

Conexiant

September 09, 2024

Cruciferous Veggies Lowered BP in Mild Hypertensives

Consuming 300g of cruciferous vegetables daily for two weeks reduced 24-hour systolic blood pressure by 2.5 mmHg in adults with mild hypertension, a randomized crossover trial found.

Conexiant

September 09, 2024

Addition of Pembrolizumab to Chemotherapy in EGFR TKI-Resistant, EGFR-Mutant, Metastatic Nonsquamous NSCLC

As reported in the Journal of Clinical Oncology by Yang et al, the phase III KEYNOTE-789 trial evaluated the survival impact of adding pembrolizumab to pemetrexed/platinum in EGFR tyrosine kinase inhi...

The ASCO Post

September 06, 2024

Lower Potassium Threshold Noninferior for AF Prevention After Surgery

A new clinical trial found that supplementing potassium only when levels fall below 3.6 mEq/L, rather than maintaining levels above 4.5 mEq/L, was just as effective in preventing atrial fibrillation after cardiac surgery, while also reducing costs.

Conexiant

September 05, 2024

COVID-19 Linked to Lower AKI and AKD Risk vs. Flu

A recent study compared the incidence and disease pattern of acute kidney injury and acute kidney disease in critically ill patients with COVID-19 and influenza A.

Conexiant

September 04, 2024

T2D Prevalence in the U.S.: A Decade of Increase and Disparities

An analysis reveals a significant rise in type 2 diabetes prevalence in the U.S. from 2012 to 2022, emphasizing the need for targeted interventions in high-risk groups and regions.

Conexiant

September 04, 2024

ESC: Quadruple Pill Surpasses Triple Therapy for Hypertension

Of resistant hypertension patients, 66% achieved BP control.

Conexiant

September 03, 2024

Pain and Demographic Factors Drive Symptom Severity in Long COVID

A retrospective case series study aimed to define the most commonly reported symptoms associated with long COVID.

Conexiant

September 03, 2024

Wearable AF Screening: More Diagnoses, No Stroke Reduction

Wearable ECG screening boosted AF diagnoses by 52% but failed to reduce stroke hospitalizations in the GUARD-AF trial, challenging assumptions about AF screening's impact on stroke prevention.

Conexiant